Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Despite initial responsiveness to both chemotherapy and radiotherapy, small cell lung cancer (SCLC) commonly relapses within months. Although neuroendocrine characteristics may be difficult to demonstrate in individual cases, a relevant expression of somatostatin receptors (SSTR) on the cell surface...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Lapa, Constantin, Hänscheid, Heribert, Wild, Vanessa, Pelzer, Theo, Schirbel, Andreas, Werner, Rudolf A., Droll, Sabine, Herrmann, Ken, Buck, Andreas K., Lückerath, Katharina
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991436/
https://ncbi.nlm.nih.gov/pubmed/26936994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7706
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires